E3 Structure and Content of Clinical Study Reports - Questions and Answers (R1)
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 29, 2013
April 29, 2020
5b7e3d17-9b0a-44df-bfcf-df3fae8991ae
Related Documents
S6 (R1) Addendum: Preclinical Safety Evaluation of Biotechnology - Derived Pharmaceuticals
Guidance DocumentMay 15, 2012Center for Drug Evaluation and Research
S2(R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use
Guidance DocumentJune 7, 2012Center for Drug Evaluation and Research
Q11 Development and Manufacture of Drug Substances
Guidance DocumentNovember 20, 2012Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.